greeksoup/ stock research

Proto Labs (PRLB) Q4 FY2023 earnings: revenue $125 million, up 8.2% on the year

Proto Labs Inc. (PRLB) reported revenue of $125 million for Q4 FY2023, the quarter ended 31 December 2023, up 8.2% on the same quarter a year earlier. Net income was $7 million, and diluted earnings per share $0.27. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2024.

Revenue$125 millionup 8.2%
Net income$7 million
Diluted EPS$0.27
QuarterQ4 FY2023ended 31 December 2023

The quarter, against the one before and a year earlier

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Revenue125131n/an/a
Cost of revenue69.271.4n/an/a
Gross profit55.859.3n/an/a
Gross margin44.6%45.4%n/a
Research and development9.510.1n/an/a
Operating income8.410.4n/an/a
Operating margin6.7%8.0%n/a
Pre-tax income9.910.7n/an/a
Income tax2.92.8n/an/a
Effective tax rate29.7%25.9%n/a
Net income7.08.0n/an/a
Net margin5.6%6.1%n/a
Diluted EPS$0.27$0.31n/an/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Operating cash flow17.224.2n/an/a
Capital expenditure18.23.1n/an/a
Free cash flow-1.021.1n/an/a
Free cash flow margin-0.8%16.1%n/a
Cash from investing-14.42.1n/an/a
Cash from financing-3.1-9.1n/an/a
Depreciation and amortisation9.39.3n/an/a
Share-based compensation4.24.4n/an/a
Buybacks4.99.0n/an/a
Diluted shares, weighted26m26mn/an/a
Shares outstanding at period end26m26mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Shareholders' equity695685n/an/a
Debt0.00.0n/an/a
Operating lease liabilities3.01.5n/an/a
Finance lease liabilities0.60.7n/an/a
Other liabilities73.597.1n/an/a
Total liabilities and equity772784n/an/a
Fixed assets254243n/an/a
Goodwill274274n/an/a
Intangible assets25.626.7n/an/a
Investments27.031.4n/an/a
Cash and equivalents83.883.5n/an/a
Receivables72.878.4n/an/a
Inventory13.713.8n/an/a
Other assets21.833.5n/an/a
Total assets772784n/an/a

Questions

What was Proto Labs' revenue in Q4 FY2023?

Proto Labs (PRLB) reported revenue of $125 million for Q4 FY2023, the quarter ended 31 December 2023, up 8.2% on the same quarter a year earlier.

How much did Proto Labs earn in Q4 FY2023?

Net income for Q4 FY2023 was $7 million, and diluted earnings per share $0.27.

When did Proto Labs report Q4 FY2023 results?

Proto Labs filed its 10-K for the year that ended with the quarter on 16 February 2024; the fourth quarter is the year less the first three.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue131125128126126122126135135136139149
Cost of revenue71.469.270.469.168.469.870.575.374.176.175.780.0
Gross profit59.355.857.556.557.252.055.759.861.360.463.669.3
Gross margin45%45%45%45%46%43%44%44%45%44%46%46%
R&D10.19.511.210.79.89.710.611.210.710.310.510.8
Operating income10.48.46.86.08.6-1.54.55.08.86.89.811.4
Operating margin8%7%5%5%7%-1%4%4%7%5%7%8%
Pre-tax income10.79.97.77.49.9-0.36.06.710.38.211.312.6
Tax rate26%30%32%38%27%n/a40%34%30%26%28%27%
Net income8.07.05.34.57.2-0.43.64.47.26.08.19.2
Net margin6%6%4%4%6%-0%3%3%5%4%6%6%
Diluted EPS$0.31$0.27$0.20$0.18$0.29-$0.01$0.15$0.18$0.30$0.25$0.33$0.37
Operating cash flow24.217.221.314.424.817.318.410.629.116.517.515.4
Capital expenditure3.118.22.64.21.60.81.31.54.18.13.56.2
Free cash flow21.1-1.018.810.223.216.517.19.125.08.414.09.2
Buybacks9.04.916.010.919.014.320.93.112.86.20.05.0
Shares outstanding26m26m25m25m25m24m24m24m24m24m24m24m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 31 December 2023, filed 16 February 2024, accession 0001628280-24-005285: the filing on EDGAR. All of Proto Labs Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install